Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing

Abroad (travel likely)Recruiting

Conditions

Stroke · Transient Ischemic Attack (TIA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Ekaterina Bakradze, MD) · ebakradze@uabmc.edu · 205-996-1658
Contact: Study coordinator (Toby Gropen, MD) · tgropen@uabmc.edu · 205-934-2401
Contact: Principal Investigator (Ekaterina Bakradze, MD)

Study leads

Ekaterina Bakradze, MD
Principal Investigator
University of Alabama at Birmingham

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Low-Field MRI in Stroke Code Patients

Acute Stroke · MRI Imaging

Abroad (travel likely)Recruiting

Leiden, Netherlands

Al Prediction of Sarcopenia Risk in Neurocritical ICU Patients

Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, Epidural Hematoma, Ischemic Stroke, Brain Neoplasms

Abroad (travel likely)Recruiting

Trabzon, Turkey (Türkiye)

Comperative Effects of Transcutaneous Auricular and Cervical Vagus Nerve Stimulation in Subacute Stroke Patients

Stroke · Stroke, Acute

Abroad (travel likely)Recruiting

Lahore, Pakistan

Virtual Stroke Units Versus Conventional Stroke Unit Care in Non-Thrombectomy-Candidate Patients.

Stroke · Stroke Hemorrhagic · Ischemic Stroke

Abroad (travel likely)Recruiting

Seville, Spain